Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer

Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer

Background: Clinical significance of primary tumor progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC) is unclear. Methods: Clinical data from 987 patients with mHSPC from multiple institutions between September 1999 and November 2023 were reviewed. The prognostic impac...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasutaka Yamada, Shinichi Sakamoto, Takuya Tsujino, Sinpei Saito, Kodai Sato, Kazuki Nishimura, Tatsuo Fukushima, Ko Nakamura, Yuki Yoshikawa, Tomohisa Matsunaga, Ryoichi Maenosono, Manato Kanesaka, Takayuki Arai, Tomokazu Sazuka, Yusuke Imamura, Kazumasa Komura, Kazuo Mikami, Kazuyoshi Nakamura, Satoshi Fukasawa, Kazuto Chiba, Yukio Naya, Maki Nagata, Atsushi Komaru, Hiroomi Nakatsu, Haruhito Azuma, Tomohiko Ichikawa
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Prostate International
Subjects:
Androgen deprivation therapy
Clinical T stage 4
Metastatic hormone-sensitive prostate cancer
Primary tumor
Tumor volume
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888224000874
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2287888224000874

Similar Items